Cancer Society hits 100 as US cancer rate falls
China's bird flu outbreak cost $6.5 billion
Regeneron, Sanofi asthma drug seen as potential game changer By Ransdell Pierson (Reuters) - A new type of asthma drug meant to attack the underlying causes of the respiratory disease slashed episodes by 87 percent in a mid-stage trial, making it a potential game changer for patients with moderate to severe disease, researchers said on Tuesday. "Overall, these are the most exciting data we've seen in asthma ...... Winning the War against Cervical Cancer
Does prostate cancer treatment help older, sick men? By Andrew M. Seaman NEW YORK (Reuters Health) - Older men with other illnesses may not live long enough to benefit from aggressive prostate cancer treatments, such as prostate removal or radiation, and they'd have to live with their side effects, says a new study. "If you're going to die of a heart attack in five years, what's the point of going th...... XenoPort to drop multiple sclerosis drug, shares fall By Vrinda Manocha (Reuters) - XenoPort Inc said it would stop development of an experimental multiple sclerosis treatment it planned to launch in 2015 after a late-stage trial failed to show significant improvement over a placebo. Shares of the company fell 26 percent to $5.03 in morning trade on the Nasdaq. "This is disappointing, given (the drug'...... UK tries out new model for gene testing in cancer patients
Peregrine Pharma agrees with FDA on lung cancer trial design (Reuters) - Peregrine Pharmaceuticals said it reached an agreement with the U.S. Food and Drug Administration on the design of a late-stage trial for its experimental lung cancer drug. The late-stage trial will compare a combination of chemotherapy and the drug, bavituximab, with chemotherapy alone. The main goal of the trial would be to show an im...... Lundbeck says drug shows improvement in depression symptoms COPENHAGEN (Reuters) - Danish pharmaceutical group Lundbeck and Japanese partner Takeda said on Saturday that data from clinical phase III studies with the antidepressant vortioxetine had shown significant improvement in patients' symptoms. Lundbeck said in a statement that the trial showed safety levels consistent with previously completed studies...... You can save this news page by submitting it to your favorite sites:
All News Lines - Local and World Wide, Updated Hourly
|

NEW YORK (AP) ? The American Cancer Society ? one of the nation's best known and influential health advocacy groups ? is 100 years old this week.
Winning the War against Cervical Cancer
